सेफिक्सिम के इंटरैक्शन

Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (इमिपेनेम और सिलास्टैटिन लेबल, चेतावनियां और सावधानियां)

AMOXIL is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AMOXIL or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins). (एमोक्सिसिलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AUGMENTIN or to other beta‑lactams (e.g., penicillins or cephalosporins). (एमोक्सिसिलिन और क्लैवुलैनेट लेबल, निषेध (कॉन्ट्राइंडिकेशन))

CONTRAINDICATIONS The use of Ampicillin is contraindicated in individuals with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to ampicillin or to other beta-lactam antibacterial drugs. (एम्पीसिलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

CONTRAINDICATIONS The use of UNASYN is contraindicated in individuals with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to ampicillin, sulbactam or to other beta-lactam antibacterial drugs (e.g., penicillins and cephalosporins). (एम्पीसिलिन और सल्बैक्टम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (एर्टापेनेम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

WARNINGS Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving beta-lactam antibacterial drugs. (नैफसिलिन लेबल, चेतावनियां)

Piperacillin and Tazobactam for Injection and Sodium Chloride Injection is contraindicated in patients with a history of allergic reactions to any of the penicillins, cephalosporins, or betalactamase inhibitors. (पाइपेरासिलिन और टैज़ोबैक्टम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (सेफिक्सिम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (एज़ट्रियोनम लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (एथाक्रिनिक एसिड लेबल, दवाओं के इंटरैक्शन)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations. (सेफिक्सिम लेबल, दवाओं के इंटरैक्शन)

Increased nephrotoxicity has been reported following concomitant administration of aminoglycoside antibiotics and cephalosporins. (जेंटामाइसिन लेबल, दवाओं के इंटरैक्शन)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (प्रोटामिन लेबल, सावधानियां)

Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (प्रोबेनेसिड लेबल, दवाओं के इंटरैक्शन)

DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (प्रोबेनेसिड और कोल्चिसिन लेबल, दवाओं के इंटरैक्शन)

Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (फ्यूरोसेमाइड लेबल, दवाओं के इंटरैक्शन)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (माइकोफेनोलेट लेबल, दवाओं के इंटरैक्शन)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफिक्सिम लेबल, चेतावनियां और सावधानियां)

Drug/Laboratory Test Interactions A false-positive reaction for ketones in the urine may occur with tests using nitroprusside but not with those using nitroferricyanide. (सेफिक्सिम लेबल, दवाओं के इंटरैक्शन)

Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (मेरोपेनेम लेबल, चेतावनियां और सावधानियां)